Global Retirement Partners LLC increased its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 23.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 974 shares of the biotechnology company’s stock after buying an additional 183 shares during the period. Global Retirement Partners LLC’s holdings in Axon Enterprise were worth $579,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. Public Sector Pension Investment Board raised its stake in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the last quarter. CIBC Asset Management Inc raised its stake in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Foundations Investment Advisors LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at about $221,000. Sequoia Financial Advisors LLC raised its stake in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after buying an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at about $814,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on AXON shares. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday. Finally, The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $561.31.
Axon Enterprise Trading Down 5.3 %
AXON stock opened at $513.22 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $265.32 and a 12-month high of $715.99. The stock has a market cap of $39.13 billion, a price-to-earnings ratio of 132.62, a PEG ratio of 5.43 and a beta of 1.05. The business’s 50-day moving average is $619.94 and its 200 day moving average is $518.66.
Insider Buying and Selling
In other news, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now directly owns 128,542 shares in the company, valued at $84,168,016.18. The trade was a 1.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,711 shares of company stock worth $5,631,561. Insiders own 6.10% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- What is Put Option Volume?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How Can Investors Benefit From After-Hours Trading
- DuPont’s Electronics Spinoff: The Start of Something Big
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.